PALO ALTO, Calif.–(BUSINESS WIRE)–Glooko, Inc., a global digital health company focused on helping clinicians address the growing challenges of glycemic safety and diabetes management across the care continuum, today announced new real-world data presented at the Diabetes Technology Society (DTS) meeting demonstrating the use of EndoTool IV for intravenous insulin dosing during labor and delivery (L&D) in pregnant individuals.The poster, “Use of a Computerized Intravenous Insulin Dosing Ap

Subscribe to Our Newsletter

We keep your data private and share your data only with third parties that make this service possible. See our Privacy Policy for more information.